Role of community pharmacists in weight management: results of a national study in Lebanon.
Community pharmacy
Lebanon
Obesity
Weight management
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
05
08
2019
accepted:
28
04
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
21
11
2020
Statut:
epublish
Résumé
Ideally situated within the community, pharmacists can be involved in a broad range of health promotion campaigns including prevention of obesity. Limited evidence is available regarding their involvement in weight management in Lebanon, a country with escalating prevalence rate of obesity. To examine the role of community pharmacists in weight management in Lebanon, specifically studying their beliefs, current practices, services, and knowledge. Using a stratified random sampling approach, a cross sectional national survey of community pharmacists was conducted (n = 341, response rate 89%). At the pharmacy, and through a face-to-face interview, pharmacists completed a multi-component questionnaire that addressed, in addition to socio-demographic and work characteristics, their beliefs, practices, knowledge in relation to weight management. Frequencies and proportions were used to describe the data. Simple and multiple linear regression analyses were used to examine the determinants of knowledge in the study population. Over 80% of study participants agreed that they have an important role to play in weight management. However, 50% of pharmacists did not agree that weight loss products are well regulated and 81.1% thought that companies marketing weight loss products are making false promises. The majority of pharmacists always/often sold weight loss products (84.7%) and counseled their patients for diet (86.3%) and physical activity (91.7%). Despite taking weight and height measurements, 50% of pharmacists rarely/never calculated BMI. Among the pharmacists who reported side effects of weight loss products (46.5%), the majority (91.3%) did so to the pharmaceutical company. The knowledge of pharmacists was better for the use of weight loss products as opposed to their side effects and interactions. Significant predictors of knowledge were holding a Masters/ PhD degree in Pharmacy, graduating from a university inside Lebanon, obtaining weight management training within the academic degree, and receiving inquiries about weight management in the pharmacy more than once daily. The results of the study provided important insights on the beliefs, practices and knowledge of community pharmacists in weight management in Lebanon. These findings could be used to inform the development of future evidence-based community pharmacists led weight management service provision nationally and internationally.
Sections du résumé
BACKGROUND
BACKGROUND
Ideally situated within the community, pharmacists can be involved in a broad range of health promotion campaigns including prevention of obesity. Limited evidence is available regarding their involvement in weight management in Lebanon, a country with escalating prevalence rate of obesity.
OBJECTIVE
OBJECTIVE
To examine the role of community pharmacists in weight management in Lebanon, specifically studying their beliefs, current practices, services, and knowledge.
METHODS
METHODS
Using a stratified random sampling approach, a cross sectional national survey of community pharmacists was conducted (n = 341, response rate 89%). At the pharmacy, and through a face-to-face interview, pharmacists completed a multi-component questionnaire that addressed, in addition to socio-demographic and work characteristics, their beliefs, practices, knowledge in relation to weight management. Frequencies and proportions were used to describe the data. Simple and multiple linear regression analyses were used to examine the determinants of knowledge in the study population.
RESULTS
RESULTS
Over 80% of study participants agreed that they have an important role to play in weight management. However, 50% of pharmacists did not agree that weight loss products are well regulated and 81.1% thought that companies marketing weight loss products are making false promises. The majority of pharmacists always/often sold weight loss products (84.7%) and counseled their patients for diet (86.3%) and physical activity (91.7%). Despite taking weight and height measurements, 50% of pharmacists rarely/never calculated BMI. Among the pharmacists who reported side effects of weight loss products (46.5%), the majority (91.3%) did so to the pharmaceutical company. The knowledge of pharmacists was better for the use of weight loss products as opposed to their side effects and interactions. Significant predictors of knowledge were holding a Masters/ PhD degree in Pharmacy, graduating from a university inside Lebanon, obtaining weight management training within the academic degree, and receiving inquiries about weight management in the pharmacy more than once daily.
CONCLUSIONS
CONCLUSIONS
The results of the study provided important insights on the beliefs, practices and knowledge of community pharmacists in weight management in Lebanon. These findings could be used to inform the development of future evidence-based community pharmacists led weight management service provision nationally and internationally.
Identifiants
pubmed: 32381084
doi: 10.1186/s12913-020-05258-7
pii: 10.1186/s12913-020-05258-7
pmc: PMC7204056
doi:
Substances chimiques
Anti-Obesity Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
386Références
Am J Pharm Educ. 2013 Sep 12;77(7):154
pubmed: 24052657
QJM. 2006 Sep;99(9):565-79
pubmed: 16916862
World J Gastroenterol. 2016 Dec 7;22(45):10071-10076
pubmed: 28018115
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):155-160
pubmed: 30641689
Int J Pharm Pract. 2011 Apr;19(2):106-14
pubmed: 21385241
Am J Health Syst Pharm. 2008 Mar 1;65(5):462-7
pubmed: 18281740
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Curr Pharm Teach Learn. 2018 May;10(5):596-601
pubmed: 29986819
J Med Toxicol. 2012 Jun;8(2):145-52
pubmed: 22351299
J Consult Clin Psychol. 1997 Feb;65(1):79-85
pubmed: 9103737
Am J Public Health. 1992 Sep;82(9):1251-7
pubmed: 1503167
Ann Pharmacother. 2003 Nov;37(11):1598-602
pubmed: 14565841
J Altern Complement Med. 2003 Feb;9(1):51-63
pubmed: 12676035
Drug Healthc Patient Saf. 2014 Jan 30;6:7-14
pubmed: 24501547
Ann Acad Med Singapore. 2010 Nov;39(11):861-7
pubmed: 21165527
Am J Health Syst Pharm. 2001 Sep 1;58(17):1645-55
pubmed: 11556659
Obes Rev. 2004 Feb;5(1):51-68
pubmed: 14969507
Metabolism. 2019 Mar;92:61-70
pubmed: 30586573
Obes Rev. 2005 May;6(2):93-111
pubmed: 15836459
Am J Pharm Educ. 2006 Dec 15;70(6):129
pubmed: 17332855
BMJ Open. 2019 Mar 8;9(3):e025074
pubmed: 30852542
J Am Pharm Assoc (Wash). 2003 Jan;43(1):56-60
pubmed: 23945805
J Food Drug Anal. 2018 Apr;26(2S):S72-S77
pubmed: 29703388
J Prim Health Care. 2016 Dec;8(4):365-371
pubmed: 29530162
Arch Toxicol. 2015 Aug;89(8):1175-91
pubmed: 25975988
Am J Pharm Educ. 2014 Mar 12;78(2):35
pubmed: 24672068
Ann Nutr Metab. 2010;57(3-4):193-203
pubmed: 21088386
Ugeskr Laeger. 1999 Sep 20;161(38):5308-13
pubmed: 10536516
Health Policy. 2013 Jul;111(2):135-48
pubmed: 23706523
Exp Biol Med (Maywood). 2019 Feb;244(2):183-192
pubmed: 30661395
BMC Public Health. 2012 Oct 11;12:863
pubmed: 23057422
Ann Hum Biol. 2012 Mar;39(2):122-8
pubmed: 22324838
Prev Med Rep. 2018 Apr 05;10:242-247
pubmed: 29868375
S Afr Med J. 1984 Mar 24;65(12):455-61
pubmed: 6701709
BMC Public Health. 2012 Sep 17;12:798
pubmed: 22984791
J Am Pharm Assoc (2003). 2003 Sep-Oct;43(5):583-9
pubmed: 14626750
Pharm World Sci. 2010 Dec;32(6):711-20
pubmed: 20703812
Hum Resour Health. 2019 Jun 24;17(1):47
pubmed: 31234863
Int J Pharm Pract. 2012 Jun;20(3):199-202
pubmed: 22554163
Int J Clin Pharm. 2014 Aug;36(4):800-6
pubmed: 25027254
Int J Pharm Pract. 2018 Dec;26(6):475-484
pubmed: 29732639
Integr Pharm Res Pract. 2015 Jul 08;4:79-89
pubmed: 29354522